At the time of writing, Vaxcyte Inc [PCVX] stock is trading at $111.08, down -2.77%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PCVX shares have lost -0.32% over the last week, with a monthly amount glided 1.77%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vaxcyte Inc [NASDAQ: PCVX] stock has seen the most recent analyst activity on December 07, 2023, when Mizuho initiated its Buy rating and assigned the stock a price target of $69. On January 03, 2023, Needham reiterated its Buy rating and revised its price target to $58 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $66 on December 15, 2022. BTIG Research initiated its recommendation with a Buy and recommended $69 as its price target on November 17, 2022.
For the past year, the stock price of Vaxcyte Inc fluctuated between $44.20 and $121.06. Currently, Wall Street analysts expect the stock to reach $124.14 within the next 12 months. Vaxcyte Inc [NASDAQ: PCVX] shares were valued at $111.08 at the most recent close of the market. An investor can expect a potential return of 11.76% based on the average PCVX price forecast.
Analyzing the PCVX fundamentals
Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at -34.76%, Pretax Profit Margin comes in at -34.42%, and Net Profit Margin reading is -34.42%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.3 and Total Capital is -0.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 110.00 points at the first support level, and at 108.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 113.15, and for the 2nd resistance point, it is at 115.23.
Ratios To Look Out For
It is important to note that Vaxcyte Inc [NASDAQ:PCVX] has a current ratio of 17.88. As well, the Quick Ratio is 17.88, while the Cash Ratio is 6.26.
Transactions by insiders
Recent insider trading involved PICKERING GRANT, CHIEF EXECUTIVE OFFICER, that happened on Oct 01 ’24 when 55000.0 shares were sold. CHIEF OPERATING OFFICER, Wassil Jim completed a deal on Oct 01 ’24 to sell 8000.0 shares. Meanwhile, SVP, GEN COUNSEL & CORP SEC Eydelman Mikhail sold 5500.0 shares on Oct 01 ’24.
